Tag Archives: aging

Resveratrol: just a fair-weather friend?

JUne 2014Since its first mention in a Japansee article in 19391, over the years many beneficial effects have been attributed to the natural compound, resveratrol—anticancer, anti-inflammatory, anti-aging—which is even used in skincare cosmetic. Although a large number of studies suggest its health benefits, recently some reports have been questioning these potentials.

Resveratrol is a natural phenol and antioxidant compound found in various colored vegetables and fruit, especially in the skin of red grape. Its name comes probably from the combination if the term resorcinol (chemical compund) and Veratrum (the plant where resveratrol was first isolated). It is thought to influence inflammation, aging, neuronal degeneration, and metabolism through the serine deacetylase, sirtuin-1 (SIRT-1), the cAMP pathway, or AMP-activated protein kinase2. However the exact mechanism of action is not known. A new role for resveratrol as a partial agonist of the estrogen receptor alpha (ERalpha) has been recently described3. According to this study, resveratrol binds to the ERalpha that is recruited to the interleukin-6 (IL-6) promoter and alters the binding of coregulators, such as SIRT-1, and the activity of transcriptional activators, leading to reduced inflammation. Resveratrol was identified in a previous screening for ERalpha agonists that inhibit IL-6 transciption4; thus resveratrol may have a selective role on the ERalpha pathway, inhibiting inflammation without promoting cell proliferation.

The amount of resveratrol found in foods varies greatly. It is mainly found in the skin of red grapes, red wine, peanuts, berries, and in lower amount in cocoa powder and dark chocolate5. However, the amount of resveratrol in foods is thought to be not enough to justify and mediate its effects. To understand whether resveratrol levels present in the diet can influence inflammation, cancer, cardiovascular disease, and mortality in humans, a prospective cohort study has been conducted in the Chianti region in Italy (InCHIANTI—“Aging in the Chianti Region”), in a population-based sample of 783 community-dwelling men and women 65 years or older who consume a diet rich in resveratrol6. The group of researchers, who have been studying aging in this population for fifteen years, measured the concentration of resveratrol metabolites present in the urine and found that it was not associated with inflammatory markers, cardiovascular disease, or cancer. This study shows that the amount of resveratrol present in the diet is not responsible for beneficial health effects. It is possible that the health benefits that come from the diet consumed in that region are not due to resveratrol, but to other substances present in the food. On the other hand resveratrol is rapidly metabolized in sulfate and glucuronide conjugates and it has long been believed that this could limit its bioavailability. However, a study from the University of Leicester shows that resveratrol is not rendered ineffective after it is metabolized by the body: it can be generated by resveratrol sulfate and be even more effective than the un-metabolized compound7.

Supplements that contain high quantity of resveratrol are available in the market. However, people should be careful with them, because we still don’t know the repercussions of high amount of resveratrol on human health. A very recent study published on the June issue of The FASEB Journal shows that the use of resveratrol during pregnancy can have beneficial effects on the blood flow in the placenta and on the liver function (decreased placental inflammation and liver triglyceride deposition), but can increase fetal pancreatic mass and exocrine proliferation, leading to unknown consequences on the development of the fetus8.

To date, there are not definitive studies on the benefits of resveratrol. The literature is full of controversial or incomplete reports. Therefore, be careful in listening to advertisements that sell resveratrol as a health serum.

1Takaoka M, Resveratrol, a new phenolic compound, from Veratrum grandiflorum. M Takaoka, Journal of the Chemical Society of Japan, 193 (2012):1090-1100.

2Tennen RI, Michishita-Kioi E, Chua KF. “Finding a target for resveratrol”. Cell 2012,148 (3): 387–9.

3Nwachukwu J,Srinivasan S, Bruno NE, Parent AA, Hughes TS, Pollock JA, Gjyshi O, Cavett V, Nowak J, Garcia-Ordonez RD, Houtman R, Griffin PR, Kojetin DJ, Katzenellenbogen JA, Conkright MD, Nettles KW. Resveratrol modulates the inflammatory response via an estrogen receptor-signal integration network. eLife, (2014).

4Srinivasan S., Nwachukwu J.C., Parent AA, Cavett V, Nowak J, Hughes TS, Kojetin DJ, Katzenellenbogen JA, and Nettles KW. Ligand-binding dynamics rewire cellular signaling via estrogen receptor-alpha. Nat Chem Biol (2013) 9, 326-332.

5Hurst WJ, Glinski JA, Miller KB, Apgar J, Davey MH, Stuart DA. “Survey of the trans-resveratrol and trans-piceid content of cocoa-containing and chocolate products”. Journal of Agricultural and Food Chemistry (2008) 56 (18): 8374–8.

6Semba RD, Luigi Ferrucci L, Bartali B, Urpí-Sarda M, Zamora-Ros R, Sun K, Cherubini A, Bandinelli S, Andres-Lacueva C. Resveratrol Levels and All-Cause Mortality in Older Community-Dwelling Adults. JAMA Internal Medicine, (2014) May 12.

7Patel KR, Andreadi C, Britton RG, Horner-Glister E, Karmokar A, Sale S, Brown VA, Brenner DE, Singh R, Steward WP, Gescher AJ and Brown K. Sulfate Metabolites Provide an Intracellular Pool for Resveratrol Generation and Induce Autophagy with Senescence. Science Translational Medicine, (2013) Oct 2;5(205).

8Roberts VHJ, Pound LD, Thorn SR, Gillingham MB, Thornburg KL, Friedman JE, Frias AE, and Grove KL. Beneficial and cautionary outcomes of resveratrol supplementation in pregnant nonhuman primates. FASEB J. (2014) June 28:2466-2477.

The life of adult survivors of childhood cancer

DecemberSurvivors of childhood and adolescent cancer have impaired health-related quality of life (HRQQL) and show accelerated aging.

A team from the St. Jude Children’s Hospital analyzed frailty and health-related symptoms in a large cohort of childhood cancer survivors (CCS) and reported them in two consecutive articles published in the Journal of Clinical Oncology in the last two months 1 -2.

In the first study, the participants were 1,662 survivors with more than 10 years from diagnosis. Among the 12 classes of symptoms considered for HRQQL there were cardiac, pulmonary, motor/movement, pain in head, in back/neck, pain involving sites other than head, neck, and back, sensation abnormalities, learning/memory, anxiety, depression, and somatization. 77%of the subjects reported more than one symptom and more than 50% had pain involving sites other than head, neck and back, and disfigurement. The prevalence of the symptoms was higher in this cohort than in the average population of the same age.

In the second study, frailty was defined by the presence of at least two of the following symptoms: low muscle mass, self-reported exhaustion, low energy expenditure, slow walking speed, and weakness. 1,992 survivors where compared to 341 subjects without cancer and 13.1% of women and 2.9% of men were qualified as frail with an average age of 33 years. Frailty was associated with smoking and body mass index in men, while lifestyle choices didn’t affect frailty in women. Also, the kind of cancer treatment, such as cranial radiation therapy (CRT) and abdominal/pelvic radiation in men and only CRT in women, affected the frailty phenotype. As expected in both sex, frailty was associated with increasing age. Frailty is usually reported in people 65 years old or older, therefore such phenotype indicates early aging.

Both these studies highlight the impact of the disease and of the treatments on CCS’ quality of life.  Advances in cancer treatment resulted in an increased number of survivors, who are facing the long term consequences of these treatments.   The importance of these reports is that they are the first reports studying quality of life and aging in such a large cohort of patients. However they present some limitations. For instance, despite the large cohort, the subjects are all from one institution in the United States. Therefore, to find new correlative associations and elucidate the biological causes and mechanisms triggering this phenotype, in the future the study has to be extended to other institutions and other Countries.

Many studies have been published on this cohort of CCS in the last year from the same group of people highlighting different aspects that impair survivors’ quality of life so accurately. If you’re intrigued after reading this post, I would suggest you to do a search on Pubmed to broaden your knowledge.

1 Huang IC, Brinkman TM, Kenzik K, Gurney JG, Ness KK, Lanctot J, Shenkman E, Robison LL, Hudson MM, Krull KR. Association between the prevalence of symptoms and health-related quality of life in adult survivors of childhood cancer: a report from the st Jude lifetime cohort study. J Clin Oncol. 2013 Nov 20;31(33):4242-51. doi: 10.1200/JCO.2012.47.8867. Epub 2013 Oct 14.

2 Ness KK, Krull KR, Jones KE, Mulrooney DA, Armstrong GT, Green DM, Chemaitilly W, Smith WA, Wilson CL, Sklar CA, Shelton K, Srivastava DK, Ali S, Robison LL, Hudson MM. Physiologic Frailty As a Sign of Accelerated Aging Among Adult Survivors of Childhood Cancer: A Report From the St Jude Lifetime Cohort Study. J Clin Oncol. 2013 Nov 18. [Epub ahead of print]